Authors
Latest:
Fertility Treatments Equally Effective in Women With, Without PCOSWomen with PCOS were more likely to begin fertility treatment with ovulation induction compared to those without PCOS.
Latest:
Challenges Facing Healthcare: The Unvaccinated COVID-19 PatientDo no harm, even though your patient might.
Latest:
New Drug Approvals in PediatricsThis past year has seen several important new drug approvals and labeling updates for children. Here is what you should know.
Latest:
Advanced Hybrid Closed-Loop Technology Could Improve Quality of Life in Type 1 DiabetesA 1-year observational follow-up of a 3-month randomized controlled trial provides insight into the benefits of advanced hybrid closed-loop system use in people with type 1 diabetes using multiple daily injections and self-monitoring of blood glucose.
Latest:
Many People Still Unaware Of Telehealth's EfficacyDespite telehealth’s rise in popularity during the height of COVID-19, many individuals still aren't aware that it's a viable option.
Latest:
Precision Prescribing Can Advance Mental Health TreatmentPharmacogenetics can inform precision prescribing practices, which in turn can solve the inefficiencies of current prescribing models.
Latest:
As Support for Medication Abortion Grows, Pharmacists Can Be Patient AdvocatesA conversation with Antonia Biggs, PhD, professor and acting director of the Advancing New Standards in Reproductive Health Program at the University of California, San Francisco.
Latest:
FDA Approves Oral Treatment for Postpartum DepressionLast August, zuranolone (Zurzuvae) became the first FDA-approved pill to treat postpartum depression in adults.
Latest:
Vaccine Update: FDA Approves Moderna COVID-19 VaccineSpikevax is now the second COVID-19 vaccine approved by regulators.
Latest:
Navigating Pediatric ADHD Medication ShortagesStimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.
Latest:
Vaccines Show Efficacy, Safety in Preventing Diseases | APhA 2025Kelly Goode, PharmD, BCPS, FAPhA, FCCP, professor in the department of pharmacotherapy and outcomes science at Virginia Commonwealth University, discusses the current landscape of immunization recommendations.
Latest:
OTC Product Roundup: Sleep AidsWhether due to jet lag, stress, major life events, or something else, there are a lot of issues that can cause short-term insomnia. Send patients on their way to a better night’s sleep with these OTC sleep aid recommendations.
Latest:
Oncology Drug Exkivity to be Voluntarily Withdrawn From US MarketExkivity remains available while Takeda works with the FDA on withdrawal timing, and the company said that patients currently taking the therapy will continue to have access after it is withdrawn.
Latest:
Dry Eye Linked to Poor Sleep QualityAll components of sleep quality were reduced significantly in individuals with dry eye disease.
Latest:
Certain Factors May Increase Long COVID Risk in ChildrenChildren who tested positive were more likely to report long COVID symptoms at 90 days than children who tested negative.
Latest:
Now #Trending: Picking and Choosing Items to Stock the Front-EndTapping into nostalgia is one way to guide front-end stock choices.
Latest:
New Drug Review: FDA Approves Lazertinib Combination Therapy for Non–Small Cell Lung CancerStudy results show improvement in progression-free survival at 22 months.
Latest:
Texting Can Boost Revenue and Patient CareEight ways texting can improve patient retention and boost revenue.
Latest:
Sickle Cell Disease Finally Getting Its DueTwo possibly curative gene therapies for the disease, which disproportionately affects Black people, are under consideration by the FDA.
Latest:
The Effects of Psychedelics in Healthy ParticipantsIn a well-blinded study, researchers investigated and directly compared the acute effects of LSD and psilocybin in healthy participants.
Latest:
FDA Grants Priority Review to Liso-Cel in Relapsed/Refractory CLL/SLLThe FDA acceptance marks the first step in addressing the unmet need for a lasting treatment option for patients with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.
Latest:
Healthcare Provider-Focused Medical Cannabis Research Study Launched by Cannabis Center of Excellence, Medicinal Genomics, and UMass DartmouthThe Cannabis Center of Excellence, Inc., Medicinal Genomics, and UMass Dartmouth have established the Healthcare Provider Knowledge, Attitudes, Practices Related to Medical Cannabis Research Study to help better understand the experiences of healthcare providers have seen with medical cannabis.
Latest:
The Pharmacist’s Role Beyond COVID-19Amid the pandemic, how effectively pharmacists embraced their role as frontline care providers could change the profession forever.
Latest:
Melphalan Flufenamide for Relapsed or Refractory Multiple MyelomaMelphalan flufenamide (Pepaxto; Oncopeptides AB) in combination with dexamethasone was granted accelerated approval on February 26, 2021, by the FDA for adult patients with relapsed or refractory multiple myeloma.
Latest:
Thriving in a Digital World: Marketing Strategies for Independent PharmaciesCut through the online noise with these digital marketing tips for your independent pharmacy.
Latest:
Q&A: Pharmacists’ Understanding of CKD Therapies, Adverse Effects | ASHP MidyearDenise Kelley, PharmD, BCPS, FASHP, joined Drug Topics to discuss various medications for chronic kidney disease and their common adverse reactions.
Latest:
New Data Shows Cebranopadol’s Potential in Acute Pain ManagementA conversation with Todd Bertoch, MD, chief medical officer for pain research at CenExel and an investigator on the ALLEVIATE-2 trial.
Latest:
Cannabinoid Hyperemesis Syndrome: Diagnosis and ManagementA deep dive for pharmacists into this frequently debilitating disorder
Latest:
The Unique Challenges, Growth in the Business of Health-System PharmacyFrom market pressures to regulatory framework, Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST, discussed growth in the business of health-system pharmacy and the challenges it has faced.
